S
Shane G. Griffin
Researcher at University of Western Sydney
Publications - 7
Citations - 831
Shane G. Griffin is an academic researcher from University of Western Sydney. The author has contributed to research in topics: Terpene & Internal medicine. The author has an hindex of 6, co-authored 6 publications receiving 768 citations. Previous affiliations of Shane G. Griffin include Eli Lilly and Company.
Papers
More filters
Journal ArticleDOI
The role of structure and molecular properties of terpenoids in determining their antimicrobial activity.
TL;DR: The minimum inhibitory concentrations (MIC) of 60 terpenoids against Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus and Candida albicans have been determined.
Journal ArticleDOI
Determination of octanol-water partition coefficient for terpenoids using reversed-phase high-performance liquid chromatography.
TL;DR: Octanol-water partition coefficients (Kow) for 57 terpenoids were measured using a RP-HPLC method and log Kow values calculated by the atom/fragment contribution method gave the best correlation with the HPLC values when compared to fragment and atomistic methods.
Journal ArticleDOI
An Agar Dilution Method for the Determination of the Minimum Inhibitory Concentration of Essential Oils
TL;DR: A standardized agar dilution MIC method, using 0.5% v/v Tween 20 as a dispersant, which provides a reliable and reproducible technique and is tested against a wide selection of bacteria, moulds and yeast.
Journal ArticleDOI
Antimicrobial activity of essential oils from Zieria
TL;DR: In this paper, essential oils extracted from species of the genus Zieria using cold methanol extraction, were used to divide the species into eight groups based on the chemical compositions of their oils using hierarchical cluster analysis.
Journal ArticleDOI
Role of the Outer Membrane of Eschericia coli AG100 and Pseudomonas aeruginosa NCTC 6749 and Resistance/Susceptibility to Monoterpenes of Similar Chemical Structure
TL;DR: Four pairs of oxygenated terpenes, with closely related chemical structures but considerably different minimum inhibitory concentration values against P. aeruginosa or E. coli, showed differences in rate of cells killed over 2 h, and addition of polymyxin B nonapeptide (PMBN) as an outer membrane permeabilising agent was found to significantly increase the initial rates and overall numbers of cells killing for all compounds.